MedTrace Logo

Phase II Dose-Ranging Study of OrthoDerm Patch for Patients With Tennis Elbow

NCT00447928 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 164

Last updated 2007-03-15

No results posted yet for this study

Summary

The purpose of the study is to evaluate the effectiveness and safety of the use of low-dose nitroglycerin transdermal patches to treat pain and function in chronic tennis elbow.

Conditions

  • Tendonitis

Interventions

DRUG

OrthoDerm transdermal nitroglycerin patch

Sponsors & Collaborators

  • Cure Therapeutics

    lead INDUSTRY

Principal Investigators

  • Ronald M Burch, MD, PhD · Cure Therapeutics, Inc

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-04-30
Completion
2007-11-30

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00447928 on ClinicalTrials.gov